VKTX Viking Therapeutics Inc

Viking Therapeutics Inc is a clinical-stage biopharmaceutical company. The Company develops therapies for metabolic and endocrine disorders. It includes portfolio of five drug candidates in clinical trials or preclinical studies.

$2.25  -0.03 (-1.32%)
As of 05/23/2022 16:00:01 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  04/29/2015
Outstanding shares:  77,373,712
Average volume:  835,955
Market cap:   $176,412,063
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      BQQG1V1
Valuation   (See tab for details)
PE ratio:   -4.25
PB ratio:   0.96
PS ratio:   0.00
Return on equity:   -31.32%
Net income %:   -1,065,836.40%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy